ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ
Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P45...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Л. Б. Лазебник [verfasserIn] Е. Д. Ли [verfasserIn] О. М. Михеева [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Архивъ внутренней медицины - SINAPS LLC, 2016, (2013), 3, Seite 20-24 |
|---|---|
| Übergeordnetes Werk: |
year:2013 ; number:3 ; pages:20-24 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.20514/2226-6704-2013-0-3-20-24 |
|---|
| Katalog-ID: |
DOAJ027962474 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ027962474 | ||
| 003 | DE-627 | ||
| 005 | 20230410105104.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2013 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.20514/2226-6704-2013-0-3-20-24 |2 doi | |
| 035 | |a (DE-627)DOAJ027962474 | ||
| 035 | |a (DE-599)DOAJe7326a40264640b4b7462685a584ab53 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a RC31-1245 | |
| 100 | 0 | |a Л. Б. Лазебник |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. | ||
| 650 | 4 | |a кислотозависимые заболевания | |
| 650 | 4 | |a ингибиторы протонной помпы | |
| 650 | 4 | |a пантопразол | |
| 650 | 4 | |a контролок | |
| 653 | 0 | |a Internal medicine | |
| 700 | 0 | |a Е. Д. Ли |e verfasserin |4 aut | |
| 700 | 0 | |a О. М. Михеева |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Архивъ внутренней медицины |d SINAPS LLC, 2016 |g (2013), 3, Seite 20-24 |w (DE-627)1760623296 |x 24116564 |7 nnns |
| 773 | 1 | 8 | |g year:2013 |g number:3 |g pages:20-24 |
| 856 | 4 | 0 | |u https://doi.org/10.20514/2226-6704-2013-0-3-20-24 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/e7326a40264640b4b7462685a584ab53 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.medarhive.ru/jour/article/view/190 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2226-6704 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2411-6564 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2013 |e 3 |h 20-24 | ||
| author_variant |
л б л лбл е д л едл о м м омм |
|---|---|
| matchkey_str |
article:24116564:2013----:: |
| hierarchy_sort_str |
2013 |
| callnumber-subject-code |
RC |
| publishDate |
2013 |
| allfields |
10.20514/2226-6704-2013-0-3-20-24 doi (DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 DE-627 ger DE-627 rakwb rus RC31-1245 Л. Б. Лазебник verfasserin aut ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine Е. Д. Ли verfasserin aut О. М. Михеева verfasserin aut In Архивъ внутренней медицины SINAPS LLC, 2016 (2013), 3, Seite 20-24 (DE-627)1760623296 24116564 nnns year:2013 number:3 pages:20-24 https://doi.org/10.20514/2226-6704-2013-0-3-20-24 kostenfrei https://doaj.org/article/e7326a40264640b4b7462685a584ab53 kostenfrei https://www.medarhive.ru/jour/article/view/190 kostenfrei https://doaj.org/toc/2226-6704 Journal toc kostenfrei https://doaj.org/toc/2411-6564 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3 20-24 |
| spelling |
10.20514/2226-6704-2013-0-3-20-24 doi (DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 DE-627 ger DE-627 rakwb rus RC31-1245 Л. Б. Лазебник verfasserin aut ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine Е. Д. Ли verfasserin aut О. М. Михеева verfasserin aut In Архивъ внутренней медицины SINAPS LLC, 2016 (2013), 3, Seite 20-24 (DE-627)1760623296 24116564 nnns year:2013 number:3 pages:20-24 https://doi.org/10.20514/2226-6704-2013-0-3-20-24 kostenfrei https://doaj.org/article/e7326a40264640b4b7462685a584ab53 kostenfrei https://www.medarhive.ru/jour/article/view/190 kostenfrei https://doaj.org/toc/2226-6704 Journal toc kostenfrei https://doaj.org/toc/2411-6564 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3 20-24 |
| allfields_unstemmed |
10.20514/2226-6704-2013-0-3-20-24 doi (DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 DE-627 ger DE-627 rakwb rus RC31-1245 Л. Б. Лазебник verfasserin aut ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine Е. Д. Ли verfasserin aut О. М. Михеева verfasserin aut In Архивъ внутренней медицины SINAPS LLC, 2016 (2013), 3, Seite 20-24 (DE-627)1760623296 24116564 nnns year:2013 number:3 pages:20-24 https://doi.org/10.20514/2226-6704-2013-0-3-20-24 kostenfrei https://doaj.org/article/e7326a40264640b4b7462685a584ab53 kostenfrei https://www.medarhive.ru/jour/article/view/190 kostenfrei https://doaj.org/toc/2226-6704 Journal toc kostenfrei https://doaj.org/toc/2411-6564 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3 20-24 |
| allfieldsGer |
10.20514/2226-6704-2013-0-3-20-24 doi (DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 DE-627 ger DE-627 rakwb rus RC31-1245 Л. Б. Лазебник verfasserin aut ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine Е. Д. Ли verfasserin aut О. М. Михеева verfasserin aut In Архивъ внутренней медицины SINAPS LLC, 2016 (2013), 3, Seite 20-24 (DE-627)1760623296 24116564 nnns year:2013 number:3 pages:20-24 https://doi.org/10.20514/2226-6704-2013-0-3-20-24 kostenfrei https://doaj.org/article/e7326a40264640b4b7462685a584ab53 kostenfrei https://www.medarhive.ru/jour/article/view/190 kostenfrei https://doaj.org/toc/2226-6704 Journal toc kostenfrei https://doaj.org/toc/2411-6564 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3 20-24 |
| allfieldsSound |
10.20514/2226-6704-2013-0-3-20-24 doi (DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 DE-627 ger DE-627 rakwb rus RC31-1245 Л. Б. Лазебник verfasserin aut ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine Е. Д. Ли verfasserin aut О. М. Михеева verfasserin aut In Архивъ внутренней медицины SINAPS LLC, 2016 (2013), 3, Seite 20-24 (DE-627)1760623296 24116564 nnns year:2013 number:3 pages:20-24 https://doi.org/10.20514/2226-6704-2013-0-3-20-24 kostenfrei https://doaj.org/article/e7326a40264640b4b7462685a584ab53 kostenfrei https://www.medarhive.ru/jour/article/view/190 kostenfrei https://doaj.org/toc/2226-6704 Journal toc kostenfrei https://doaj.org/toc/2411-6564 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2013 3 20-24 |
| language |
Russian |
| source |
In Архивъ внутренней медицины (2013), 3, Seite 20-24 year:2013 number:3 pages:20-24 |
| sourceStr |
In Архивъ внутренней медицины (2013), 3, Seite 20-24 year:2013 number:3 pages:20-24 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок Internal medicine |
| isfreeaccess_bool |
true |
| container_title |
Архивъ внутренней медицины |
| authorswithroles_txt_mv |
Л. Б. Лазебник @@aut@@ Е. Д. Ли @@aut@@ О. М. Михеева @@aut@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
1760623296 |
| id |
DOAJ027962474 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027962474</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410105104.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2013 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.20514/2226-6704-2013-0-3-20-24</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027962474</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJe7326a40264640b4b7462685a584ab53</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC31-1245</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Л. Б. Лазебник</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">кислотозависимые заболевания</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ингибиторы протонной помпы</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">пантопразол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">контролок</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Е. Д. Ли</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">О. М. Михеева</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Архивъ внутренней медицины</subfield><subfield code="d">SINAPS LLC, 2016</subfield><subfield code="g">(2013), 3, Seite 20-24</subfield><subfield code="w">(DE-627)1760623296</subfield><subfield code="x">24116564</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:20-24</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.20514/2226-6704-2013-0-3-20-24</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/e7326a40264640b4b7462685a584ab53</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.medarhive.ru/jour/article/view/190</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2226-6704</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2411-6564</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">20-24</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Л. Б. Лазебник |
| spellingShingle |
Л. Б. Лазебник misc RC31-1245 misc кислотозависимые заболевания misc ингибиторы протонной помпы misc пантопразол misc контролок misc Internal medicine ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| authorStr |
Л. Б. Лазебник |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760623296 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RC31-1245 |
| illustrated |
Not Illustrated |
| issn |
24116564 |
| topic_title |
RC31-1245 ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ кислотозависимые заболевания ингибиторы протонной помпы пантопразол контролок |
| topic |
misc RC31-1245 misc кислотозависимые заболевания misc ингибиторы протонной помпы misc пантопразол misc контролок misc Internal medicine |
| topic_unstemmed |
misc RC31-1245 misc кислотозависимые заболевания misc ингибиторы протонной помпы misc пантопразол misc контролок misc Internal medicine |
| topic_browse |
misc RC31-1245 misc кислотозависимые заболевания misc ингибиторы протонной помпы misc пантопразол misc контролок misc Internal medicine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Архивъ внутренней медицины |
| hierarchy_parent_id |
1760623296 |
| hierarchy_top_title |
Архивъ внутренней медицины |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760623296 |
| title |
ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| ctrlnum |
(DE-627)DOAJ027962474 (DE-599)DOAJe7326a40264640b4b7462685a584ab53 |
| title_full |
ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| author_sort |
Л. Б. Лазебник |
| journal |
Архивъ внутренней медицины |
| journalStr |
Архивъ внутренней медицины |
| callnumber-first-code |
R |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
txt |
| container_start_page |
20 |
| author_browse |
Л. Б. Лазебник Е. Д. Ли О. М. Михеева |
| class |
RC31-1245 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Л. Б. Лазебник |
| doi_str_mv |
10.20514/2226-6704-2013-0-3-20-24 |
| author2-role |
verfasserin |
| title_sort |
использование ингибиторов протонной помпы для лечения кислотозависимых заболеваний |
| callnumber |
RC31-1245 |
| title_auth |
ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| abstract |
Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. |
| abstractGer |
Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. |
| abstract_unstemmed |
Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
3 |
| title_short |
ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ |
| url |
https://doi.org/10.20514/2226-6704-2013-0-3-20-24 https://doaj.org/article/e7326a40264640b4b7462685a584ab53 https://www.medarhive.ru/jour/article/view/190 https://doaj.org/toc/2226-6704 https://doaj.org/toc/2411-6564 |
| remote_bool |
true |
| author2 |
Е. Д. Ли О. М. Михеева |
| author2Str |
Е. Д. Ли О. М. Михеева |
| ppnlink |
1760623296 |
| callnumber-subject |
RC - Internal Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.20514/2226-6704-2013-0-3-20-24 |
| callnumber-a |
RC31-1245 |
| up_date |
2024-07-03T14:59:12.294Z |
| _version_ |
1803570383206481921 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027962474</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410105104.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2013 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.20514/2226-6704-2013-0-3-20-24</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027962474</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJe7326a40264640b4b7462685a584ab53</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC31-1245</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Л. Б. Лазебник</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic oxidase system, which depends on cytochrome P450. Pantoprazole (Controloc) does not accumulate, and in case of repeated drug intake during the day pharmacokinetics does not change. So, there is no need for special selection of the dose of pantoprazole in elderly patients or in patients with renal insufficiency and with moderate hepatic impairment.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">кислотозависимые заболевания</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ингибиторы протонной помпы</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">пантопразол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">контролок</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Е. Д. Ли</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">О. М. Михеева</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Архивъ внутренней медицины</subfield><subfield code="d">SINAPS LLC, 2016</subfield><subfield code="g">(2013), 3, Seite 20-24</subfield><subfield code="w">(DE-627)1760623296</subfield><subfield code="x">24116564</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:20-24</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.20514/2226-6704-2013-0-3-20-24</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/e7326a40264640b4b7462685a584ab53</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.medarhive.ru/jour/article/view/190</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2226-6704</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2411-6564</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">20-24</subfield></datafield></record></collection>
|
| score |
7.4031916 |